Literature DB >> 21310262

Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst.

Fernanda Sangalli-Leite1, Liliana Scorzoni, Ana Cecilia Mesa-Arango, Celia Casas, Enrique Herrero, Maria José Soares Mendes Gianinni, Juan Luis Rodríguez-Tudela, Manuel Cuenca-Estrella, Oscar Zaragoza.   

Abstract

We studied the effects of Amphotericin B (AmB) on Cryptococcus neoformans using different viability methods (CFUs enumeration, XTT assay and propidium iodide permeability). After 1h of incubation, there were no viable colonies when the cells were exposed to AmB concentrations ≥ 1 mg/L. In the same conditions, the cells did not become permeable to propidium iodide, a phenomenon that was not observed until 3h of incubation. When viability was measured in parallel using XTT assay, a result consistent with the CFUs was obtained, although we also observed a paradoxical effect in which at high AmB concentrations, a higher XTT reduction was measured than at intermediate AmB concentrations. This paradoxical effect was not observed after 3h of incubation with AmB, and lack of XTT reduction was observed at AmB concentrations higher than 1mg/L. When stained with dihydrofluorescein, AmB induced a strong intracellular oxidative burst. Consistent with oxidative damage, AmB induced protein carbonylation. Our results indicate that in C. neoformans, Amphotericin B causes intracellular damage mediated through the production of free radicals before damage on the cell membrane, measured by propidium iodide uptake.
Copyright © 2011 Institut Pasteur. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310262     DOI: 10.1016/j.micinf.2011.01.015

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  33 in total

1.  The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.

Authors:  Ana Cecilia Mesa-Arango; Nuria Trevijano-Contador; Elvira Román; Ruth Sánchez-Fresneda; Celia Casas; Enrique Herrero; Juan Carlos Argüelles; Jesús Pla; Manuel Cuenca-Estrella; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.

Authors:  Suélen Andreia Rossi; Haroldo Cesar de Oliveira; Daniel Agreda-Mellon; José Lucio; Maria José Soares Mendes-Giannini; Jesús Pablo García-Cambero; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  Oxidative Stress Response Tips the Balance in Aspergillus terreus Amphotericin B Resistance.

Authors:  Emina Jukic; Michael Blatzer; Wilfried Posch; Marion Steger; Ulrike Binder; Cornelia Lass-Flörl; Doris Wilflingseder
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

4.  Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus.

Authors:  Elena Shekhova; Olaf Kniemeyer; Axel A Brakhage
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 5.  Structural insights on biologically relevant cationic membranes by ESR spectroscopy.

Authors:  Julio H K Rozenfeld; Evandro L Duarte; Tiago R Oliveira; M Teresa Lamy
Journal:  Biophys Rev       Date:  2017-08-23

6.  Melanin protects Paracoccidioides brasiliensis from the effects of antimicrobial photodynamic inhibition and antifungal drugs.

Authors:  Ludmila Matos Baltazar; Silvia Maria Cordeiro Werneck; Betânia Maria Soares; Marcus Vinicius L Ferreira; Danielle G Souza; Marcos Pinotti; Daniel Assis Santos; Patrícia Silva Cisalpino
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

7.  A new look at the antibiotic amphotericin B effect on Candida albicans plasma membrane permeability and cell viability functions.

Authors:  Barbara Chudzik; Mateusz Koselski; Aleksandra Czuryło; Kazimierz Trębacz; Mariusz Gagoś
Journal:  Eur Biophys J       Date:  2015-01-04       Impact factor: 1.733

Review 8.  Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility.

Authors:  Nina T Grossman; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

Review 9.  Sphingolipids as targets for treatment of fungal infections.

Authors:  Rodrigo Rollin-Pinheiro; Ashutosh Singh; Eliana Barreto-Bergter; Maurizio Del Poeta
Journal:  Future Med Chem       Date:  2016-08-09       Impact factor: 3.808

10.  Micafungin Enhances the Human Macrophage Response to Candida albicans through β-Glucan Exposure.

Authors:  José Pedro Guirao-Abad; Ruth Sánchez-Fresneda; Francisco Machado; Juan Carlos Argüelles; María Martínez-Esparza
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.